Virtual Reality for Multiple Sclerosis rehabilitation

Emma De Keersmaecker; David Beckwée; Stijn Denissen; Guy Nagels; Eva Swinnen

doi:10.1002/14651858.CD013834

Virtual Reality for Multiple Sclerosis rehabilitation

Emma De Keersmaecker, David Beckwée, Stijn Denissen, Guy Nagels, Eva Swinnen

Research output: Contribution to journal › Scientific review › peer-review

1 Citation (Scopus)

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: 1) To determine the effectiveness of virtual reality interventions compared with alternative or no intervention in people with Multiple Sclerosis (MS) on: gait and balance function, 2) To determine the effectiveness of virtual reality interventions compared with alternative or no intervention in people with MS on upper limb function; cognitive function; fatigue; global motor function; activity limitation; participation restriction and quality of life and adverse events.

Original language	English
Article number	CD013834
Journal	Cochrane Database of Systematic Reviews
Volume	2020
Issue number	12
DOIs	https://doi.org/10.1002/14651858.CD013834
Publication status	Published - 8 Jan 2021

Bibliographical note

Funding Information:
Stijn Denissen is funded by an industrial doctoral grant for a PhD trajectory in collaboration with icometrix NV, appointed by Flanders Innovation and Entrepreneurship (HBC.2019.2579, www.vlaio.be). However, this does not cause a conflict of interest with regard to icometrix'day-to-day business.

Funding Information:
Guy Nagels is a Senior Clinical Investigator fellow funded by the Research Foundation – Flanders (FWO) (1805620N). He is also on a 10% secondment as medical director neurology from UZ Brussel to icometrix NV and a minority shareholder of icometrix NV. However, this does not cause a conflict of interest with regard to icometrix' day to day business.

Funding Information:
Emma De Keersmaecker is a Strategic Basic Research fellow funded by the Research Foundation – Flanders (FWO) (1S58419N).

Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Copyright:
Copyright 2022 Elsevier B.V., All rights reserved.

Keywords

Multiple Sclerosis
Virtual reality

Access to Document

10.1002/14651858.CD013834

Link to publication in Scopus

ROB2 assessment for Cochrane review: VR for MS rehabilitation
De Keersmaecker, E. (Creator), Zenodo, 24 Mar 2022
DOI: 10.5281/zenodo.6382664
Dataset

Cite this

@article{118d2bbcf7df476a962fb2e9adfbd242,

title = "Virtual Reality for Multiple Sclerosis rehabilitation",

abstract = "This is a protocol for a Cochrane Review (intervention). The objectives are as follows: 1) To determine the effectiveness of virtual reality interventions compared with alternative or no intervention in people with Multiple Sclerosis (MS) on: gait and balance function, 2) To determine the effectiveness of virtual reality interventions compared with alternative or no intervention in people with MS on upper limb function; cognitive function; fatigue; global motor function; activity limitation; participation restriction and quality of life and adverse events.",

keywords = "Multiple Sclerosis, Virtual reality",

author = "{De Keersmaecker}, Emma and David Beckw{\'e}e and Stijn Denissen and Guy Nagels and Eva Swinnen",

note = "Funding Information: Stijn Denissen is funded by an industrial doctoral grant for a PhD trajectory in collaboration with icometrix NV, appointed by Flanders Innovation and Entrepreneurship (HBC.2019.2579, www.vlaio.be). However, this does not cause a conflict of interest with regard to icometrix'day-to-day business. Funding Information: Guy Nagels is a Senior Clinical Investigator fellow funded by the Research Foundation – Flanders (FWO) (1805620N). He is also on a 10% secondment as medical director neurology from UZ Brussel to icometrix NV and a minority shareholder of icometrix NV. However, this does not cause a conflict of interest with regard to icometrix' day to day business. Funding Information: Emma De Keersmaecker is a Strategic Basic Research fellow funded by the Research Foundation – Flanders (FWO) (1S58419N). Publisher Copyright: Copyright {\textcopyright} 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Copyright: Copyright 2022 Elsevier B.V., All rights reserved.",

year = "2021",

month = jan,

day = "8",

doi = "10.1002/14651858.CD013834",

language = "English",

volume = "2020",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "12",

}

TY - JOUR

T1 - Virtual Reality for Multiple Sclerosis rehabilitation

AU - De Keersmaecker, Emma

AU - Beckwée, David

AU - Denissen, Stijn

AU - Nagels, Guy

AU - Swinnen, Eva

N1 - Funding Information: Stijn Denissen is funded by an industrial doctoral grant for a PhD trajectory in collaboration with icometrix NV, appointed by Flanders Innovation and Entrepreneurship (HBC.2019.2579, www.vlaio.be). However, this does not cause a conflict of interest with regard to icometrix'day-to-day business. Funding Information: Guy Nagels is a Senior Clinical Investigator fellow funded by the Research Foundation – Flanders (FWO) (1805620N). He is also on a 10% secondment as medical director neurology from UZ Brussel to icometrix NV and a minority shareholder of icometrix NV. However, this does not cause a conflict of interest with regard to icometrix' day to day business. Funding Information: Emma De Keersmaecker is a Strategic Basic Research fellow funded by the Research Foundation – Flanders (FWO) (1S58419N). Publisher Copyright: Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Copyright: Copyright 2022 Elsevier B.V., All rights reserved.

PY - 2021/1/8

Y1 - 2021/1/8

N2 - This is a protocol for a Cochrane Review (intervention). The objectives are as follows: 1) To determine the effectiveness of virtual reality interventions compared with alternative or no intervention in people with Multiple Sclerosis (MS) on: gait and balance function, 2) To determine the effectiveness of virtual reality interventions compared with alternative or no intervention in people with MS on upper limb function; cognitive function; fatigue; global motor function; activity limitation; participation restriction and quality of life and adverse events.

AB - This is a protocol for a Cochrane Review (intervention). The objectives are as follows: 1) To determine the effectiveness of virtual reality interventions compared with alternative or no intervention in people with Multiple Sclerosis (MS) on: gait and balance function, 2) To determine the effectiveness of virtual reality interventions compared with alternative or no intervention in people with MS on upper limb function; cognitive function; fatigue; global motor function; activity limitation; participation restriction and quality of life and adverse events.

KW - Multiple Sclerosis

KW - Virtual reality

UR - http://www.scopus.com/inward/record.url?scp=85103069441&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013834

DO - 10.1002/14651858.CD013834

M3 - Scientific review

VL - 2020

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 12

M1 - CD013834

ER -

Virtual Reality for Multiple Sclerosis rehabilitation

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Datasets

ROB2 assessment for Cochrane review: VR for MS rehabilitation

Cite this